Functional Mushroom Research 2026: Turkey Tail, Lion's Mane and What the New Science Shows

Medicinal & Functional Mushrooms · 8 May 2026 · 8 min read

Functional mushroom research 2026 has produced some notable new results. In early May, the Functional Mushroom Council released two new studies on turkey tail and lion's mane — and a separate paper published in PLOS ONE reported, for the first time in a laboratory setting, that lion's mane extract promoted nerve regeneration in retinal cells. Here is what the science actually says and why it matters for anyone following this space.

What Is the Functional Mushroom Council?

The Functional Mushroom Council (FMC) is a North American non-profit organisation that launched at the start of 2026. Its members include mushroom growers, supplement brands, and independent researchers. Together, they work to establish quality standards, fund research, and publish evidence-based information about medicinal mushrooms for both consumers and professionals.

In early May 2026, the FMC announced a significant expansion. New member brands joined, new innovation centres opened, and a multi-year research programme began. Specifically, the programme addresses three priorities. First, standardised quality benchmarks for mushroom extracts. Second, detailed bioactive compound profiles — especially beta-glucans. Third, a direct comparison between North American-grown and imported mushroom products.

That third priority matters because the market has a quality problem. Many products sold as lion's mane or reishi contain very little of the actual fruiting body. Consequently, their levels of active compounds are low. As a result, consumers frequently spend money on products that deliver very little. The FMC aims to address this with published standards and independent testing.

Functional Mushroom Research 2026: Turkey Tail Studies

Turkey tail (Trametes versicolor) is one of the most studied mushroom species in the scientific literature. Researchers know it best for two polysaccharide compounds: PSK (polysaccharide-K) and PSP (polysaccharide peptide). Both have been the subject of extensive laboratory and clinical investigation. Notably, Japan and China have authorised PSK alongside certain cancer treatments. However, that authorisation covers a specific pharmaceutical-grade extract only — not food supplements sold in the EU.

The new 2026 Host Defense study is titled "Calm Under Challenge: Immune-Balancing and Stress-Quenching." It examined how turkey tail extract interacted with immune system activity under physical and psychological stress. Importantly, the researchers focused on immune modulation rather than simple stimulation. In laboratory and preclinical models, they observed that turkey tail extracts appeared to influence the balance of immune signalling rather than simply increasing overall immune activity.

Beyond immune signalling, the study also examined gut microbiome interaction. The data suggested that turkey tail extracts selectively supported certain beneficial gut bacteria. In turn, those bacteria are associated with immune regulation in the published scientific literature. You can read the peer-reviewed background on PSK research at PubMed Central.

Why You Cannot Buy Turkey Tail in Europe — And What You Can Do About It

Functional Mushroom Research 2026: Lion's Mane and Retinal Nerve Cells

Lion's mane (Hericium erinaceus) has attracted substantial scientific interest in recent years, primarily because laboratory studies have shown that its compounds stimulate the production of nerve growth factor (NGF) — a protein involved in the growth and maintenance of certain neurons. Consequently, researchers have been investigating lion's mane in the context of neurodegenerative conditions, cognitive ageing, and mood. However, no health claims based on these findings have received EFSA authorisation for food supplements in the EU. That distinction matters for anyone buying supplements in Europe.

The February 2026 study published in PLOS ONE examined a new area entirely. Researchers found that extracts from Hericium erinaceus promoted neurite outgrowth in retinal ganglion cells in a laboratory model. Furthermore, a specific purified compound called Erinacine S showed a measurable effect on retinal nerve cell activity in this preclinical context. In glaucoma, retinal ganglion cells gradually deteriorate. For that reason, this finding opens a new direction for future research.

Nevertheless, this is early-stage laboratory research. It does not demonstrate that lion's mane supplements prevent or treat glaucoma, or any other eye condition, in humans. The study authors themselves describe it as a preclinical finding that warrants further investigation. The full open-access paper is available at PLOS ONE for those who want to read the methodology directly.

The Functional Mushroom Market in 2026: Rapid Growth, Uneven Quality

The global functional mushroom supplement market was valued at approximately $10.48 billion in 2025. Analysts project growth at a compound annual rate of around 12.35%. At that pace, the market could reach close to $30 billion by 2034. Meanwhile, the lion's mane segment alone was already valued at $680 million in 2025.

This rapid growth, however, brings a significant quality challenge. A large proportion of supplements sold as lion's mane or reishi use mycelium grown on grain. They do not use the fruiting body of the mushroom itself. Because the grain substrate remains in the final product, beta-glucan content is typically very low. In practice, therefore, buyers often pay premium prices for products with minimal measurable levels of the compounds researchers actually study.

As a result, the FMC's quality guidelines are increasingly relevant. When evaluating a functional mushroom supplement, two things are worth checking on the label: whether the product specifies fruiting body extract, and whether it states a beta-glucan percentage. The Food Navigator analysis of the 2026 functional mushroom market covers this quality divergence in further detail.

The Most Studied Species: A Research Overview for 2026

Lion's mane and turkey tail receive the most attention in current research, but several other species have comparable levels of scientific investigation behind them. Below is a summary of the four most studied functional mushroom species, based on published preclinical and clinical literature — framed as research context, not as health claims.

For a closer look at reishi, see our dedicated post on reishi — the mushroom of immortality. Additionally, our post on functional mushroom supplements and immune health compares all four species in the context of the published research.

How to Evaluate Functional Mushroom Supplements in 2026

The new functional mushroom research in 2026 confirms that these species attract serious scientific attention. In addition, the published findings are interesting enough to justify further investigation. At the same time, the research is largely preclinical or early-stage clinical. Most studies are small. Moreover, regulators in the EU have not yet authorised health claims for any functional mushroom supplement.

If you are interested in functional mushrooms, start by reading the actual research. Understand what it does and does not show. Then choose products with transparent labelling: the species, the part of mushroom used, the extraction method, and the beta-glucan content. The FMC's multi-year research programme will publish more detailed quality and dosing guidance through 2027 and 2028. In the meantime, we will continue reporting on functional mushroom research 2026 as new studies emerge.